Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Crinetics Pharmaceuticals, Inc. | crnx-ex312_6.htm |
| EX-31.1 - EX-31.1 - Crinetics Pharmaceuticals, Inc. | crnx-ex311_7.htm |
| 10-Q - 10-Q - Crinetics Pharmaceuticals, Inc. | crnx-10q_20200930.htm |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Crinetics Pharmaceuticals, Inc. (the “Company”) hereby certifies, to his knowledge, that:
(i) the accompanying Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended September 30, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
|
/s/ R. Scott Struthers, Ph.D. |
|
R. Scott Struthers, Ph.D. |
|
President and Chief Executive Officer |
Date: November 6, 2020
CERTIFICATION OF CHIEF FINANCIAL OFFICER
Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Crinetics Pharmaceuticals, Inc. (the “Company”) hereby certifies, to his knowledge, that:
(i) the accompanying Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended September 30, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
|
/s/ Marc J.S. Wilson |
|
Marc J.S. Wilson |
|
Chief Financial Officer |
Date: November 6, 2020